Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription. [electronic resource]
Producer: 20090522Description: 571-9 p. digitalISSN:- 1521-0103
- 3T3-L1 Cells
- Adiponectin -- blood
- Adipose Tissue -- drug effects
- Animals
- Biomarkers -- analysis
- Blood Glucose -- metabolism
- Body Weight -- drug effects
- Cilostazol
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Fibroblasts -- drug effects
- Gene Expression -- drug effects
- Glucose Transporter Type 4 -- biosynthesis
- Insulin -- blood
- Male
- Mice
- Mice, Inbred C57BL
- PPAR gamma -- biosynthesis
- Phosphodiesterase Inhibitors -- administration & dosage
- Receptors, Leptin -- deficiency
- Tetrazoles -- administration & dosage
- Transcriptional Activation -- drug effects
- Triglycerides -- blood
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Vascular Cell Adhesion Molecule-1 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.